We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWBI icon
1001
Northwest Bancshares
NWBI
$2.29B
$138K 0.01%
11,508
-759
-6% -$9.61K
QTRX icon
1002
Quanterix
QTRX
$116M
$137K 0.01%
+21,010
New +$175K
ACH
1003
Accendra Health
ACH
$93.4M
$137K 0.01%
+15,146
New +$160K
DBI icon
1004
Designer Brands
DBI
$330M
$137K 0.01%
37,423
-277
-0.7% -$1.3K
RNW icon
1005
ReNew
RNW
$2.49B
$136K 0.01%
+23,039
New +$148K
AVDX
1006
DELISTED
AvidXchange
AVDX
$135K 0.01%
15,976
-10,325
-39% -$95.4K
ADT icon
1007
ADT
ADT
$5.5B
$135K 0.01%
16,600
+4,800
+41% +$36.2K
ELDN icon
1008
Eledon Pharmaceuticals
ELDN
$280M
$133K 0.01%
39,371
-35,205
-47% -$145K
WTTR icon
1009
Select Water Solutions
WTTR
$2.71B
$133K 0.01%
+12,680
New +$154K
SD icon
1010
SandRidge Energy
SD
$526M
$133K 0.01%
+11,629
New +$138K
AMCR icon
1011
Amcor
AMCR
$21.9B
$132K 0.01%
+2,730
New +$134K
RBBN icon
1012
Ribbon Communications
RBBN
$361M
$132K 0.01%
33,718
-200
-0.6% -$843
KYTX icon
1013
Kyverna Therapeutics
KYTX
$483M
$130K 0.01%
67,546
+23,784
+54% +$70.3K
IMMR icon
1014
Immersion
IMMR
$255M
$128K 0.01%
16,944
+4,559
+37% +$37.4K
LYFT icon
1015
Lyft
LYFT
$6.65B
$128K 0.01%
+10,805
New +$141K
NTLA icon
1016
Intellia Therapeutics
NTLA
$1.68B
$127K 0.01%
+17,817
New +$180K
GENK icon
1017
GEN Restaurant Group
GENK
$10.7M
$126K 0.01%
22,792
-1,948
-8% -$12.1K
GPRO icon
1018
GoPro
GPRO
$109M
$125K 0.01%
187,920
– –
NVAX icon
1019
Novavax
NVAX
$1.29B
$123K 0.01%
+19,213
New +$159K
SAGE
1020
DELISTED
Sage Therapeutics
SAGE
$122K 0.01%
15,367
-16,833
-52% -$123K
PAMT
1021
PAMT Corp
PAMT
$284M
$121K 0.01%
+10,000
New +$144K
YALA
1022
Yalla Group
YALA
$818M
$116K 0.01%
+22,152
New +$95.3K
TWI icon
1023
Titan International
TWI
$465M
$114K 0.01%
13,636
+736
+6% +$6.08K
VNDA icon
1024
Vanda Pharmaceuticals
VNDA
$300M
$113K 0.01%
24,708
+9,496
+62% +$44.3K
NPKI
1025
NPK International
NPKI
$1.18B
$113K 0.01%
19,470
– –
39 40
41
42 43

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.